Top

Quality of Life Research

Gepubliceerd in:

26-04-2021

The association between diabetic complications and health-related quality of life in patients with type 2 diabetes: a cross-sectional study from Iran

Auteurs: Hassan Karami, Maryam Shirvani Shiri, Aziz Rezapour, Ranaa Sarvari Mehrabadi, Somayeh Afshari

Gepubliceerd in: Quality of Life Research | Uitgave 7/2021

Abstract

Introduction

This study aimed to investigate the health-related quality of life (HRQoL) of type 2 diabetic patients and its relationship with the complications of diabetes in Farashband County, Fars, Iran.

Methods

Data of this cross-sectional study were collected by a researcher-made demographic questionnaire, EuroQol-5 Dimensions questionnaire (EQ-5D) and Visual Analog Scale (VAS) and also from patient records. Multivariate regression model was used to investigate the net effect of diabetes complications on HRQoL after controlling for other independent variables.

Results

A total of 685 patients with a mean age of 58.36 and a disease duration of 7.64 years participated in the study. The mean EQ-5D and EQ-VAS scores of all patients were 0.64 and 56.53, respectively. The HRQoL dimensions in which the largest portions of the population had problems were Pain/Discomfort (77.23%) and Anxiety/Depression (63.50%). Among the studied diabetic patients, women, divorcees, and widows were more likely to report problems in all dimensions of HRQoL, and people without complications, people with university degrees, and employed people were more likely to report fewer problems in these dimensions (P < 0.05). After controlling for the effect of all independent variables in the multivariate regression model, a significant negative relationship was found between diabetes complications and EQ-5D: β = − 0.149 (95% CI − 0.186, − 0.112) and EQ-VAS: β = − 6.697 (95% CI − 9.947, − 3.747). This indicates that for each additional diabetic complication, 0.149 and 6.697 units of EQ-5D Index and EQ-VAS were reduced, respectively.

Conclusion

This study indicated that type 2 diabetic patients in the studied region, especially those with complications, suffer from poor HRQoL. Therefore, more attention should be paid to the main determinants of HRQoL when adopting policies for diabetes management in order to ultimately improve the HRQoL of these patients.

vorige artikel The prediction of mortality by quality of life assessed with the WHOQOL-BREF: a longitudinal analysis at the domain and item levels using a seven-year follow-up period

volgende artikel What’s important when caring for a loved one? Population-based preference weights for the Adult Social Care Outcomes Toolkit for informal carers (ASCOT-Carer) for Austria

Akbart International Dibetes Federation. Diabetes Atlas. Ninth edition. https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.

Moradi, Y., Baradaran, H. R., Djalalinia, S., Chinekesh, A., Khamseh, M. E., Dastoorpoor, M., et al. (2019). Complications of type 2 diabetes in Iranian population: An updated systematic review and meta-analysis. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 13(3), 2300–2312.CrossRef

Böckerman, P., Johansson, E., & Saarni, S. I. (2011). Do established health-related quality-of-life measures adequately capture the impact of chronic conditions on subjective well-being? Health Policy, 100(1), 91–95. https://doi.org/10.1016/j.healthpol.2010.10.008CrossRefPubMed

Arifin, B., Purba, F. D., Herman, H., Adam, J. M. F., Atthobari, J., Schuiling-Veninga, C. C. M., et al. (2020). Comparing the EQ-5D-3 L and EQ-5D-5 L: Studying measurement and scores in Indonesian type 2 diabetes mellitus patients. Health and Quality of Life Outcomes, 18(1), 22. https://doi.org/10.1186/s12955-020-1282-yCrossRefPubMedPubMedCentral

Gu, S., Wang, X., Shi, L., Sun, Q., Hu, X., Gu, Y., et al. (2020). Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation.

Mielck, A., Vogelmann, M., & Leidl, R. (2014). Health-related quality of life and socioeconomic status: Inequalities among adults with a chronic disease. Health and Quality of Life Outcomes, 12(1), 58. https://doi.org/10.1186/1477-7525-12-58CrossRefPubMedPubMedCentral

Morgan, C. L., Currie, C. J., Stott, N. C. H., Smithers, M., Butler, C. C., & Peters, J. R. (2000). The prevalence of multiple diabetes-related complications. Diabetic Medicine, 17(2), 146–151. https://doi.org/10.1046/j.1464-5491.2000.00222.xCrossRefPubMed

Gomes, A. R., & Santos, L. (2017). Prevalência das complicações da diabetes mellitus no ACeS Santo Tirso/Trofa: estudodescritivo. Revista Portuguesa de MedicinaGeral e Familiar, 33(4), 252–260.

Deshpande, A. D., Harris-Hayes, M., & Schootman, M. (2008). Epidemiology of diabetes and diabetes-related complications. Physical Therapy, 88(11), 1254–1264.CrossRef

10.

Pham, T. B., Nguyen, T. T., Truong, H. T., Trinh, C. H., Du, H. N. T., Ngo, T. T., et al. (2020). Effects of diabetic complications on health-related quality of life impairment in Vietnamese patients with type 2 diabetes. Journal of Diabetes Research, 2020, 4360804. https://doi.org/10.1155/2020/4360804CrossRefPubMedPubMedCentral

11.

Jiao, F., Wong, C. K. H., Gangwani, R., Tan, K. C. B., Tang, S. C. W., & Lam, C. L. K. (2017). Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: Decrements associated with individual complication and number of complications. Health and Quality of Life Outcomes, 15(1), 125.CrossRef

12.

Solli, O., Stavem, K., & Kristiansen, I. S. (2010). Health-related quality of life in diabetes: The associations of complications with EQ-5D scores. Health and Quality of Life Outcomes, 8(1), 18. https://doi.org/10.1186/1477-7525-8-18CrossRefPubMedPubMedCentral

13.

Luk, A., Zhang, Y., Ko, G., Brown, N., Ozaki, R., Tong, P., et al. (2014). Health-related quality of life in Chinese patients with type 2 diabetes: An analysis of the Joint Asia Diabetes Evaluation (JADE) Program. Journal of Diabetes Metabolism, 5(333), 2.

14.

Mohtasham-Amiri, Z., Barzigar, A., Kolamroudi, H. R., Hoseini, S., Rezvani, S., Shakib, R. J., et al. (2015). Prevalence, awareness and control of diabetes in urban area of north of Iran, 2009. International Journal of Diabetes in Developing Countries, 35(3), 346–350.CrossRef

15.

Katibeh, M., Hosseini, S., Soleimanizad, R., Manaviat, M., Kheiri, B., Khabazkhoob, M., et al. (2015). Prevalence and risk factors of diabetes mellitus in a central district in Islamic Republic of Iran: A population-based study on adults aged 40–80 years. EMHJ-Eastern Mediterranean Health Journal, 21(6), 412–419.

16.

Janghorbani, M., & Amini, M. (2004). Cataract in type 2 diabetes mellitus in Isfahan, Iran: Incidence and risk factors. Ophthalmic Epidemiology, 11(5), 347–358.CrossRef

17.

Abdollahi, A., Daneshpazhooh, M., Amirchaghmaghi, E., Sheikhi, S., Eshrati, B., & Bastanhagh, M. H. (2007). Dermopathy and retinopathy in diabetes: Is there an association? Dermatology, 214(2), 133–136. https://doi.org/10.1159/000098572CrossRefPubMed

18.

Amini, M., Safaei, H., & Aminorroaya, A. (2007). The incidence of microalbuminuria and its associated risk factors in type 2 diabetic patients in Isfahan, Iran. The Review of Diabetic Studies: RDS, 4(4), 242.CrossRef

19.

Zakerkish, M., Shahbazian, H. B., Shahbazian, H., Mahmoud Latifi, S., & Moravej Aleali, A. (2013). Albuminuria and its correlates in type 2 diabetic patients. Iranian Journal of Kidney Diseases, 7(4).

20.

Soltani, Z., & Keshavarzi, D. (2016). Species composition of mosquitoes (Diptera: Culicidae) in Farashband district, southwest of Iran. Journal of Entomological and Acarological Research, 48(3), 372–377. https://doi.org/10.4081/jear.2016.6268CrossRef

21.

Baygi, M. Z., Seyedin, H., Salehi, M., & Sirizi, M. J. (2015). Structural and contextual dimensions of Iranian primary health care system at local level. Iranian Red Crescent Medical Journal, 17(1), e17222.

22.

Majdzadeh, R. (2012). Family physician implementation and preventive medicine; opportunities and challenges. International Journal of Preventive Medicine, 3(10), 665.PubMedPubMedCentral

23.

Pickard, A. S., Wilke, C. T., Lin, H.-W., & Lloyd, A. (2007). Health utilities using the EQ-5D in studies of cancer. Pharmacoeconomics, 25(5), 365–384. https://doi.org/10.2165/00019053-200725050-00002CrossRefPubMed

24.

EuroQol - a new facility for the measurement of health-related quality of life (1990). Health Policy, 16(3), 199–208. https://doi.org/10.1016/0168-8510(90)90421-9.

25.

Goudarzi, R., Sari, A. A., Zeraati, H., Rashidian, A., Mohammad, K., & Amini, S. (2019). Valuation of quality weights for EuroQol 5-dimensional health states with the time trade-off method in the Capital of Iran. Value in Health Regional Issues, 18, 170–175.CrossRef

26.

Zare, F., Ameri, H., Madadizadeh, F., & Aghaei, M. R. (2021). Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life -years) for patients with type 2 diabetes in Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2021.01.009CrossRef

27.

Pan, C.-W., Wang, S., Wang, P., Xu, C.-L., & Song, E. (2018). Diabetic retinopathy and health-related quality of life among Chinese with known type 2 diabetes mellitus. Quality of Life Research, 27(8), 2087–2093. https://doi.org/10.1007/s11136-018-1876-6CrossRefPubMed

28.

Cohen, J., Cohen, P., West, S. G., & Aiken, L. S. (2013). Applied multiple regression/correlation analysis for the behavioral sciences. Routledge.CrossRef

29.

Simon Pickard, A., Wilke, C., Jung, E., Patel, S., Stavem, K., & Lee, T. A. (2008). Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respiratory Medicine, 102(4), 519–536. https://doi.org/10.1016/j.rmed.2007.11.016CrossRefPubMed

30.

Janssen, M. F., Lubetkin, E. I., Sekhobo, J. P., & Pickard, A. S. (2011). The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabetic Medicine, 28(4), 395–413. https://doi.org/10.1111/j.1464-5491.2010.03136.xCrossRefPubMed

31.

Javanbakht, M., Abolhasani, F., Mashayekhi, A., Baradaran, H. R., & Jahangirinoudeh, Y. (2012). Health Related quality of life in patients with type 2 diabetes mellitus in Iran: A national survey. PLoS ONE, 7(8), e44526. https://doi.org/10.1371/journal.pone.0044526CrossRefPubMedPubMedCentral

32.

Abedini, M. R., Bijari, B., Miri, Z., ShakhsEmampour, F., & Abbasi, A. (2020). The quality of life of the patients with diabetes type 2 using EQ-5D-5 L in Birjand. Health and Quality of Life Outcomes, 18(1), 18. https://doi.org/10.1186/s12955-020-1277-8CrossRefPubMedPubMedCentral

33.

Lee, W. J., Song, K.-H., Noh, J. H., Choi, Y. J., & Jo, M.-W. (2012). Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. Journal of Korean Medical Science, 27(3), 255–260.CrossRef

34.

Arifin, B., Idrus, L. R., van Asselt, A. D., Purba, F. D., Perwitasari, D. A., Thobari, J. A., et al. (2019). Health-related quality of life in Indonesian type 2 diabetes mellitus outpatients measured with the Bahasa version of EQ-5D. Quality of Life Research, 28(5), 1179–1190.CrossRef

35.

Holmes, J., McGill, S., Kind, P., Bottomley, J., Gillam, S., & Murphy, M. (2000). Health-related quality of life in type 2 diabetes (T2ARDIS-2). Value in Health, 3, S47–S51.CrossRef

36.

Redekop, W. K., Koopmanschap, M. A., Stolk, R. P., Rutten, G. E. H. M., Wolffenbuttel, B. H. R., & Niessen, L. W. (2002). Health-related quality of life and treatment satisfaction in Dutch patients with type 2 diabetes. Diabetes Care, 25(3), 458–463. https://doi.org/10.2337/diacare.25.3.458CrossRefPubMed

37.

Sakamaki, H., Ikeda, S., Ikegami, N., Uchigata, Y., Iwamoto, Y., Origasa, H., et al. (2006). Measurement of HRQL using EQ-5D in patients with type 2 diabetes mellitus in Japan. Value in Health, 9(1), 47–53.CrossRef

38.

Saadatjoo, S. A., Rezvanee, M. R., Tabyee, S. H., & Oudi, D. (2012). Life quality comparison in type 2 diabetic patients and none diabetic persons. Modern Care Journal, 9(1).

39.

Ahmadi, A., Hasanzadeh, J., RahimiMadiseh, M., & Lashkari, L. (2011). Effective factors in the quality of life in patients with type 2 diabetes in Chaharmahal & Bakhteyari Province. Journal of North Khorasan University of Medical Sciences, 3(17), 2011.

40.

Fu, A. Z., Qiu, Y., Radican, L., & Luo, N. (2011). Marginal differences in health-related quality of life of diabetic patients with and without macrovascular comorbid conditions in the United States. Quality of Life Research, 20(6), 825–832. https://doi.org/10.1007/s11136-010-9819-xCrossRefPubMed

41.

Venkataraman, K., Wee, H. L., Leow, M. K. S., Tai, E. S., Lee, J., Lim, S. C., et al. (2013). Associations between complications and health-related quality of life in individuals with diabetes. Clinical Endocrinology, 78(6), 865–873. https://doi.org/10.1111/j.1365-2265.2012.04480.xCrossRefPubMed

42.

Zhang, Y., Wu, J., Chen, Y., & Shi, L. (2020). EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China. Diabetes Therapy, 1–12.

43.

Mukuria, C., & Brazier, J. (2013). Valuing the EQ-5D and the SF-6D health states using subjective well-being: A secondary analysis of patient data. Social Science & Medicine, 77, 97–105.CrossRef

44.

Ostovaneh, M. R., Poustchi, H., Hemming, K., Marjani, H., Pourshams, A., Nateghi, A., et al. (2015). Polypill for the prevention of cardiovascular disease (PolyIran): Study design and rationale for a pragmatic cluster randomized controlled trial. European Journal of Preventive Cardiology, 22(12), 1609–1617. https://doi.org/10.1177/2047487314550803CrossRefPubMed

45.

Roshandel, G., Khoshnia, M., Poustchi, H., Hemming, K., Kamangar, F., Gharavi, A., et al. (2019). Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): A pragmatic, cluster-randomised trial. The Lancet, 394(10199), 672–683. https://doi.org/10.1016/S0140-6736(19)31791-XCrossRef

46.

Malekzadeh, F., Marshall, T., Pourshams, A., Gharravi, M., Aslani, A., Nateghi, A., et al. (2010). A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (‘polypill’) on cardiovascular risk factors. International Journal of Clinical Practice, 64(9), 1220–1227. https://doi.org/10.1111/j.1742-1241.2010.02412.xCrossRefPubMed

Titel: The association between diabetic complications and health-related quality of life in patients with type 2 diabetes: a cross-sectional study from Iran
Auteurs: Hassan Karami
Maryam Shirvani Shiri
Aziz Rezapour
Ranaa Sarvari Mehrabadi
Somayeh Afshari
Publicatiedatum: 26-04-2021
Uitgeverij: Springer International Publishing
Gepubliceerd in: Quality of Life Research / Uitgave 7/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-021-02792-7

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Introduction

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 7/2021

Study objectives in clinical trials in older patients with solid malignancies: do we measure what matters?

Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China

Social support and quality of life among rural family caregivers of persons with severe mental illness in Sichuan Province, China: mediating roles of care burden and loneliness

Enhancing validity, reliability and participation in self-reported health outcome measurement for children and young people: a systematic review of recall period, response scale format, and administration modality

Dutch utility weights for the EORTC cancer-specific utility instrument: the Dutch EORTC QLU-C10D

Trajectories of health-related quality of life in children of parents with mental health problems: results of the BELLA study